retatrutide maximum dose clinical trials in adults with obesity over 104 weeks in the highest group had 30.3% weight loss. Nearly 2/3 reached BMI < 30 1 in 3 reached BMI < 25 Trial Data Dosing Schedule :

Use the Federal Poverty Level Calculator to calculate your households FPL percentage based on your income and household size

Retatrutide: Not yet approved anywhere, still in clinical trials as of 2024

The reduction in appetite in those mice was associated with a decreased rate of gastric emptying of solid meal

Fatty Acid Acylation and Albumin Binding Pharmacokinetics Source: PubMed PMID: 26308095 Summary: This medicinal chemistry study described the design and structure-activity relationships of GLP-1 analogs with C-18 fatty diacid modifications

KFF health tracking poll May 2024: the publics use and views of GLP-1 drugs

For insured patients, copays for the pill and injection should be similar once both are on formulary